From Today to Tomorrow: Iberdomide’s New Approval in Multiple Myeloma and What It Means for Practice

Content Format:

Video

Credit Type:

--

Credits:

--
From Today to Tomorrow: the Evolving Clinical Role of CELMoD Agents in Multiple Myeloma

Content Format:

Video

Credit Type:

--

Credits:

--